|
|
|
Insider
Information: |
Goldstein Joseph L |
Relationship: |
Director |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
6,382 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,393,041 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
6,382 |
|
|
Total
Value |
$6,393,041 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
10.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-23 |
6,382 |
2003-10-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2008-01-22 |
4 |
OE |
$7.66 |
$38,300 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2010-05-14 |
4 |
OE |
$25.43 |
$127,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2011-02-10 |
4 |
OE |
$15.80 |
$79,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2011-05-04 |
4 |
OE |
$28.81 |
$144,050 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2012-03-15 |
4 |
OE |
$18.61 |
$186,100 |
D/D |
10,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2012-03-26 |
4 |
OE |
$18.61 |
$93,050 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2013-01-09 |
4 |
OE |
$57.11 |
$285,550 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2013-04-01 |
4 |
OE |
$24.41 |
$122,050 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2013-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2010-12-16 |
4 |
D |
$31.80 |
$150,064 |
D/D |
(4,719) |
5,281 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2011-01-26 |
4 |
D |
$34.35 |
$157,976 |
D/D |
(4,599) |
5,401 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-21 |
4 |
S |
$617.18 |
$617,180 |
D/D |
(1,000) |
5,643 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-09-22 |
4 |
AS |
$552.36 |
$11,047 |
D/D |
(20) |
5,643 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-10-05 |
4 |
AS |
$600.00 |
$5,527,200 |
D/D |
(9,212) |
5,643 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-09-21 |
4 |
AS |
$543.19 |
$9,102,446 |
D/D |
(16,554) |
5,663 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
5,891 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-06-07 |
4 |
AS |
$525.00 |
$1,013,250 |
D/D |
(1,930) |
5,891 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-09-10 |
4 |
AS |
$650.00 |
$1,611,350 |
D/D |
(2,479) |
5,891 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2014-08-14 |
4 |
S |
$347.65 |
$695,300 |
D/D |
(2,000) |
6,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
191 |
6,082 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2022-03-30 |
4 |
AS |
$700.00 |
$1,701,700 |
D/D |
(2,431) |
6,082 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
6,247 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2023-02-06 |
4 |
AS |
$800.00 |
$2,890,400 |
D/D |
(3,613) |
6,247 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
6,382 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2024-01-23 |
4 |
AS |
$950.00 |
$2,571,650 |
D/D |
(2,707) |
6,382 |
0 |
% |
|
157 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|